The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Racemetirosine     2-amino-3-(4-hydroxyphenyl)- 2-methyl...

Synonyms: Racemetirosina, alpha-MPT, AmbotzHAA5370, alpha-Methyltyrosine, alpha-Methyl-p-tyrosine, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Racemetirosine


Psychiatry related information on Racemetirosine


High impact information on Racemetirosine


Chemical compound and disease context of Racemetirosine


Biological context of Racemetirosine


Anatomical context of Racemetirosine


Associations of Racemetirosine with other chemical compounds


Gene context of Racemetirosine


Analytical, diagnostic and therapeutic context of Racemetirosine


  1. Reduction in the size of a pheochromocytoma pulmonary metastasis by metyrosine therapy. Serri, O., Comtois, R., Bettez, P., Dubuc, G., Buu, N.T., Kuchel, O. N. Engl. J. Med. (1984) [Pubmed]
  2. Hypercalcemia in pheochromocytoma. Evidence for a novel mechanism. Stewart, A.F., Hoecker, J.L., Mallette, L.E., Segre, G.V., Amatruda, T.T., Vignery, A. Ann. Intern. Med. (1985) [Pubmed]
  3. Surgical management of pheochromocytoma with the use of metyrosine. Perry, R.R., Keiser, H.R., Norton, J.A., Wall, R.T., Robertson, C.N., Travis, W., Pass, H.I., Walther, M.M., Linehan, W.M. Ann. Surg. (1990) [Pubmed]
  4. Acute hemodynamic effects of norepinephrine inhibition in patients with severe chronic congestive heart failure. Franciosa, J.A., Schwartz, D.E. J. Am. Coll. Cardiol. (1989) [Pubmed]
  5. Side effects of sympatholytic antihypertensive drugs. Engelman, K. Hypertension (1988) [Pubmed]
  6. Structure-anti-Parkinson activity relationships in the aminoadamantanes. Influence of bridgehead substitution. Henkel, J.G., Hane, J.T., Gianutsos, G. J. Med. Chem. (1982) [Pubmed]
  7. Circadian variations in the effect of alpha-methyl-p-tyrosine on avoidance learning. Tapp, W.N., Holloway, F.A. Psychopharmacology (Berl.) (1979) [Pubmed]
  8. Testing cyclic AMP mediation of memory: reversal of alpha-methyl-p-tyrosine-induced amnesia. Chutae, D.L., Villiger, J.W., Kirton, N.F. Psychopharmacology (Berl.) (1981) [Pubmed]
  9. Effects of penfluridol and other drugs on apomorphine-induced stereotyped behavior in monkeys. Shintomi, K., Yamamura, M. Eur. J. Pharmacol. (1975) [Pubmed]
  10. Synergistic interaction of D1 and D2 dopamine receptors in the modulation of the reinforcing effect of brain stimulation. Nakajima, S., Liu, X., Lau, C.L. Behav. Neurosci. (1993) [Pubmed]
  11. A correlation between platelet monoamine oxidase activity and plasma prolactin concentrations in man. Kleinman, J.E., Potkin, S., Rogol, A., Buchsbaum, M.S., Murphy, D.L., Gillin, J.C., Nasrallah, H.A., Wyatt, R.J. Science (1979) [Pubmed]
  12. Dopaminergic agents: influence on serotonin in the molluscan nervous system. Stefano, G.B., Catapane, E., Aiello, E. Science (1976) [Pubmed]
  13. Inhibition of dopamine synthesis in chronic schizophrenia. Clinical ineffectiveness of metyrosine. Nasrallah, H.A., Donnelly, E.F., Bigelow, L.B., Rivera-Calimlim, L., Rogol, A., Potkin, S., Rauscher, F.P., Wyatt, R.J. Arch. Gen. Psychiatry (1977) [Pubmed]
  14. Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson's disease. Drukarch, B., Jongenelen, C.A., Schepens, E., Langeveld, C.H., Stoof, J.C. J. Neurosci. (1996) [Pubmed]
  15. Catecholamine depletion produces irrepressible saccadic eye movements in normal humans. Tychsen, L., Sitaram, N. Ann. Neurol. (1989) [Pubmed]
  16. Failure of alpha-methyltyrosine to prevent hypertensive crisis in pheochromocytoma. Ram, C.V., Meese, R., Hill, S.C. Arch. Intern. Med. (1985) [Pubmed]
  17. Inactivation of tyrosine hydroxylase by pterin substrates following phosphorylation by cyclic AMP-dependent protein kinase. Roskoski, R., Wilgus, H., Vrana, K.E. Mol. Pharmacol. (1990) [Pubmed]
  18. Effects of locally applied dopamine to the nucleus accumbens on the motor activity of normal rats and following alpha-methyltyrosine or reserpine. Wachtel, H., Ahlenius, S., Andén, N.E. Psychopharmacology (Berl.) (1979) [Pubmed]
  19. Differential effects of neuroleptic and serotonergic drugs on amphetamine-induced hypothermia in mice. Boschi, G., Launay, N. Neuropharmacology (1985) [Pubmed]
  20. Dopamine, acetylcholine, and GABA effects in acute dystonia in primates. Casey, D.E., Gerlach, J., Christensson, E. Psychopharmacology (Berl.) (1980) [Pubmed]
  21. Endogenous catecholamines suppress thyrotropin secretion during the early follicular phase of the menstrual cycle. Plosker, S.M., Rabinovici, J., Montalvo, M., Jaffe, R.B. J. Clin. Endocrinol. Metab. (1995) [Pubmed]
  22. Inhibition of endogenous catecholamine synthesis augments early follicular phase luteinizing hormone secretion. Plosker, S.M., Rabinovici, J., Jaffe, R.B. J. Clin. Endocrinol. Metab. (1991) [Pubmed]
  23. Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant alpha-synuclein. Zhou, Z.D., Yap, B.P., Gung, A.Y., Leong, S.M., Ang, S.T., Lim, T.M. Exp. Cell Res. (2006) [Pubmed]
  24. Angiotensin II increases norepinephrine turnover in the anteroventral third ventricle of spontaneously hypertensive rats. Tsukashima, A., Tsuchihashi, T., Abe, I., Nakamura, K., Uchimura, H., Fujishima, M. Hypertension (1996) [Pubmed]
  25. Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats. Sato, Y., Ando, K., Fujita, T. Hypertension (1987) [Pubmed]
  26. Activation of melatonin receptor sites retarded the depletion of norepinephrine following inhibition of synthesis in the C3H/HeN mouse hypothalamus. Fang, J.M., Dubocovich, M.L. J. Neurochem. (1990) [Pubmed]
  27. Inhibition and facilitation of antidromically identified tubero-infundibular neurones following stimulation of the median eminence in the rat. Sawaki, Y., Yagi, K. J. Physiol. (Lond.) (1976) [Pubmed]
  28. Effects of sympathicolytic and sympathicomimetic drugs on pineal ultrastructure in the domestic pig. Lewczuk, B., Przybylska-Gornowicz, B. J. Pineal Res. (1997) [Pubmed]
  29. Expression of human tyrosine hydroxylase cDNA in invertebrate cells using a baculovirus vector. Ginns, E.I., Rehavi, M., Martin, B.M., Weller, M., O'Malley, K.L., LaMarca, M.E., McAllister, C.G., Paul, S.M. J. Biol. Chem. (1988) [Pubmed]
  30. Selective depletion of dopamine, octopamine, and 5-hydroxytryptamine in the nervous tissue of the cockroach (Periplaneta americana). Sloley, B.D., Orikasa, S. J. Neurochem. (1988) [Pubmed]
  31. Is there a direct correlation between the activities of various lysosomal enzymes and prolactin secretion in the rat anterior pituitary? Nagy, I., Rappay, G., Makara, G.B., Horvath, G., Bacsy, E., MacLeod, R.M. Endocrinology (1983) [Pubmed]
  32. Circadian variations in the activity of tyrosine hydroxylase, tyrosine aminotransferase, and tryptophan hydroxylase: relationship to catecholamine metabolism. Cahill, A.L., Ehret, C.F. J. Neurochem. (1981) [Pubmed]
  33. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide. Tanimoto, K., Tamminga, C.A., Chase, T.N., Nilaver, G. Endocrinology (1987) [Pubmed]
  34. Antagonist of pituitary adenylate cyclase activating polypeptide suppresses prolactin secretion without changing the activity of dopamine neurons in lactating rats. Tohei, A., Matsuzaki, M., Kogo, H. Neuroendocrinology (2001) [Pubmed]
  35. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia. Nicoletti, I., Filipponi, P., Fedeli, L., Sfrappini, M., Gregorini, G., Ambrosi, F., Santeusanio, F. Horm. Res. (1984) [Pubmed]
  36. Effects of tyrosine hydroxylase mutants on locomotor activity in Drosophila: a study in functional genomics. Pendleton, R.G., Rasheed, A., Sardina, T., Tully, T., Hillman, R. Behav. Genet. (2002) [Pubmed]
  37. Role of the central adrenergic system in the regulation of prostaglandin biosynthesis in rat brain. Weidenfeld, J., Kahbha, K., Reches, A., Shohami, E. J. Neurochem. (1992) [Pubmed]
  38. Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. A long-term trial using double-blind crossover technique. Wålinder, J., Skott, A., Carlsson, A., Roos, B.E. Arch. Gen. Psychiatry (1976) [Pubmed]
  39. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation. Hu, X.T., Wachtel, S.R., Galloway, M.P., White, F.J. J. Neurosci. (1990) [Pubmed]
  40. Paraventricular norepinephrine release mediates glucoprivic suppression of pulsatile luteinizing hormone secretion. Nagatani, S., Tsukamura, H., Murahashi, K., Bucholtz, D.C., Foster, D.L., Maeda, K. Endocrinology (1996) [Pubmed]
WikiGenes - Universities